Carignan D, Thérien A, Rioux G, Paquet G, Gagné ML, et al. Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine. Vaccine. 2015;33:7245. doi:10.1016/j.vaccine.2015.10.123
Rioux G, Carignan D, Russell A, Bolduc M, Gagné MÈ, et al. Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine. J Nanobiotechnology. 2016;14:43. doi:10.1186/s12951-016-0200-2